title: [Myopathy with rhabdomyolysis as an adverse effect of simultaneous treatment with cerivastatin and gemfibrozil].
abstract: Drug-induced myopathy and/or rhabdomyolysis have been reported with use of some statins and fibric acid derivatives. The risk of adverse effects is increased with their concomitant use. We report the case of myopathy with rhabdomyolysis during the concomitant use of cerivastatin and gemfibrozil.
authors.affiliation: Zavod za klinicku farmakologiju, Klinika za unutarnje bolesti Rebro, KBC Zagreb, Kispatićeva 12, 10000 Zagreb.
authors.forename: Mirjana
authors.initials: M
authors.lastname: Huić
authors.forename: Branimir
authors.initials: B
authors.lastname: Anić
authors.forename: Nada
authors.initials: N
authors.lastname: Cikes
authors.forename: Dubravka
authors.initials: D
authors.lastname: Bosnić
authors.forename: Mirna
authors.initials: M
authors.lastname: Sentić
authors.forename: Jasenka
authors.initials: J
authors.lastname: Markeljević
authors.forename: Miroslav
authors.initials: M
authors.lastname: Mayer
authors.forename: Leo
authors.initials: L
authors.lastname: Pazanin
mesh_terms: D000368:Aged; D004347:Drug Interactions; D005260:Female; D015248:Gemfibrozil / Q000009:adverse effects*; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000009:adverse effects*; D000960:Hypolipidemic Agents / Q000009:adverse effects*; D009135:Muscular Diseases / Q000139:chemically induced*; D011725:Pyridines / Q000009:adverse effects*; D012206:Rhabdomyolysis / Q000139:chemically induced*
chemical_list: D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D000960:Hypolipidemic Agents; D011725:Pyridines; C086276:cerivastatin; D015248:Gemfibrozil